Website Changes
10/02/2022
Radiotherapy Plus Temozolomide With or Without Nimotuzumab Against the Newly Diagnosed EGFR-Positive Glioblastoma: A Retrospective Cohort Study
10/01/2022
Biosensor Detects Brain Tumors With Less Than a Drop of Blood
09/30/2022
Webinar on A Promising New Targeted Radiation Therapy for Leptomeningeal Metastases in Breast Cancer, Lung Cancer, and Other Malignancies
09/23/2022
Increasing blood-brain barrier permeability with Acoustic Cluster Therapy (ACT®) to enhance drug delivery in the brain
09/23/2022
The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies
09/22/2022
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide
09/20/2022
New Radiation Therapy Delays Brain Cancer Regrowth, Protects Healthy Tissue
09/15/2022
Brain Tumor Guide For The Newly Diagnosed - new Kindle Edition available!
09/15/2022
SonALAsense Forges Ahead with First Patient Dosing for Devastating Childhood Brain Cancer
09/11/2022
Cancer Chomp (a brain tumor event)
09/09/2022
Musella Foundation Brain Tumor Treatment Copayment Assistance program is now closed to new patients
09/08/2022
Cancer Commons Presents Free Webinar on Biomarker Testing and Why it Matters
09/06/2022
IQ-AI`s trial investigator talks through the importance of its brain cancer treatment
09/06/2022
Musella Foundation awards another brain tumor research grant!
08/26/2022
xCures and Oblato announce the launch of a Compassionate Use program for OKN-007
08/24/2022
Musella Foundation Awards Two More Brain Tumor Research Grants!
08/21/2022
Local musician fights cancer to get back to doing what he loves
08/21/2022
Intratumoral oncolytic herpes virus G47? for residual or recurrent glioblastoma: a phase 2 trial
08/16/2022
Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma
08/16/2022
Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields
08/16/2022
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma
08/15/2022
Cancer Commons and Musella Foundation For Brain Tumor Research Launch Pilot Study of Individualized Treatments for GBM
08/15/2022
Musella Foundation Awards Two More Brain Tumor Research Grants!
08/11/2022
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003
08/09/2022
National Walk To End Brain Tumors to be held Sept 24, 2022 in New Egypt, NJ
which delivers brain tumor news and additions
to the website via RSS.